SignalPoint Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$503K Hold
6,791
0.12% 135
2024
Q3
$452K Buy
6,791
+100
+1% +$7.27K 0.11% 165
2024
Q2
$618K Hold
6,691
0.17% 129
2024
Q1
$639K Hold
6,691
0.18% 126
2023
Q4
$510K Sell
6,691
-54
-0.8% -$3.76K 0.15% 130
2023
Q3
$467K Hold
6,745
0.15% 130
2023
Q2
$636K Hold
6,745
0.19% 105
2023
Q1
$558K Hold
6,745
0.18% 111
2022
Q4
$503K Buy
6,745
+80
+1% +$6.17K 0.18% 119
2022
Q3
$550K Hold
6,665
0.21% 98
2022
Q2
$633K Hold
6,665
0.23% 93
2022
Q1
$785K Buy
6,665
+10
+0.2% +$1.12K 0.25% 91
2021
Q4
$862K Sell
6,655
-330
-5% -$38.5K 0.26% 88
2021
Q3
$791K Hold
6,985
0.25% 94
2021
Q2
$723K Buy
6,985
+312
+5% +$29.4K 0.24% 99
2021
Q1
$558K Buy
6,673
+40
+0.6% +$3.38K 0.2% 106
2020
Q4
$605K Hold
6,633
0.23% 99
2020
Q3
$529K Hold
6,633
0.22% 100
2020
Q2
$458K Hold
6,633
0.21% 95
2020
Q1
$417K Hold
6,633
0.22% 90
2019
Q4
$516K Buy
6,633
+108
+2% +$8.43K 0.22% 100
2019
Q3
$478K Hold
6,525
0.21% 97
2019
Q2
$402K Buy
+6,525
New +$395K 0.19% 131
2019
Q1
Sell
-7,164
Closed -$366K 213
2018
Q4
$366K Buy
7,164
+396
+6% +$20K 0.18% 142
2018
Q3
$393K Sell
6,768
-9
-0.1% -$440 0.18% 141
2018
Q2
$329K Sell
6,777
-894
-12% -$41.7K 0.16% 157
2018
Q1
$357K Sell
7,671
-57
-0.7% -$2.48K 0.17% 147
2017
Q4
$290K Sell
7,728
-399
-5% -$14.6K 0.14% 163
2017
Q3
$296K Buy
+8,127
New +$310K 0.15% 156
2017
Q1
Sell
-12,429
Closed -$388K 168
2016
Q4
$388K Buy
12,429
+705
+6% +$22.8K 0.1% 174
2016
Q3
$471K Sell
11,724
-1,344
-10% -$50.6K 0.13% 144
2016
Q2
$434K Hold
13,068
0.18% 129
2016
Q1
$384K Hold
13,068
0.16% 131
2015
Q4
$344K Sell
13,068
-330
-2% -$8.57K 0.15% 119
2015
Q3
$317K Buy
13,398
+960
+8% +$23.2K 0.14% 119
2015
Q2
$295K Hold
12,438
0.12% 137
2015
Q1
$295K Buy
12,438
+1,860
+18% +$41.7K 0.12% 137
2014
Q4
$225K Buy
+10,578
New +$213K 0.1% 147

Other funds holding EW